AU751471B2 - Method and kit for evaluation of HIV mutations - Google Patents

Method and kit for evaluation of HIV mutations Download PDF

Info

Publication number
AU751471B2
AU751471B2 AU92493/98A AU9249398A AU751471B2 AU 751471 B2 AU751471 B2 AU 751471B2 AU 92493/98 A AU92493/98 A AU 92493/98A AU 9249398 A AU9249398 A AU 9249398A AU 751471 B2 AU751471 B2 AU 751471B2
Authority
AU
Australia
Prior art keywords
primer
seq
sequencing
hiv
primers
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU92493/98A
Other languages
English (en)
Other versions
AU9249398A (en
Inventor
James M. Dunn
Jean-Michel Lacroix
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Healthcare LLC
Original Assignee
Visible Genetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/938,641 external-priority patent/US6007983A/en
Application filed by Visible Genetics Inc filed Critical Visible Genetics Inc
Publication of AU9249398A publication Critical patent/AU9249398A/en
Application granted granted Critical
Publication of AU751471B2 publication Critical patent/AU751471B2/en
Assigned to BAYER HEALTHCARE LLC reassignment BAYER HEALTHCARE LLC Alteration of Name(s) in Register under S187 Assignors: VISIBLE GENETICS INC.
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6816—Hybridisation assays characterised by the detection means
    • C12Q1/6818—Hybridisation assays characterised by the detection means involving interaction of two or more labels, e.g. resonant energy transfer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6869—Methods for sequencing
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/702—Specific hybridization probes for retroviruses
    • C12Q1/703—Viruses associated with AIDS

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • AIDS & HIV (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU92493/98A 1997-09-26 1998-09-28 Method and kit for evaluation of HIV mutations Ceased AU751471B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/938,641 US6007983A (en) 1995-12-22 1997-09-26 Method and kit for evaluation of HIV mutations
US08/938641 1997-09-26
PCT/CA1998/000913 WO1999016910A1 (fr) 1997-09-26 1998-09-28 Procede et ensemble de materiel d'evaluation de mutations vih

Publications (2)

Publication Number Publication Date
AU9249398A AU9249398A (en) 1999-04-23
AU751471B2 true AU751471B2 (en) 2002-08-15

Family

ID=25471725

Family Applications (1)

Application Number Title Priority Date Filing Date
AU92493/98A Ceased AU751471B2 (en) 1997-09-26 1998-09-28 Method and kit for evaluation of HIV mutations

Country Status (5)

Country Link
EP (1) EP1017856A1 (fr)
JP (1) JP2001518313A (fr)
AU (1) AU751471B2 (fr)
CA (1) CA2302201A1 (fr)
WO (1) WO1999016910A1 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6265152B1 (en) * 1995-12-22 2001-07-24 Visible Genetics Inc. Method and kit for evaluation of HIV mutations
JP4824236B2 (ja) 1999-07-09 2011-11-30 ジェン−プローブ・インコーポレーテッド 核酸増幅によるｈｉｖ−１の検出
GB2395008B (en) * 1999-10-15 2004-07-21 Visible Genetics Inc Method and kit for evaluation of HIV mutations
GB2395787A (en) * 1999-10-15 2004-06-02 Visible Genetics Inc Method and kit for evaluation of HIV mutations
EP2020450B9 (fr) * 2000-09-01 2011-09-14 Gen-Probe Incorporated Amplification de séquences HIV-1 pour la détection de séquences associées à des mutations résistantes aux médicaments
US6582920B2 (en) 2000-09-01 2003-06-24 Gen-Probe Incorporated Amplification of HIV-1 RT sequences for detection of sequences associated with drug-resistance mutations
PL1794327T3 (pl) 2004-09-14 2017-04-28 Argos Therapeutics, Inc. Niezależna od szczepu amplifikacja patogenów i szczepionki przeciwko nim

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997023650A2 (fr) * 1995-12-22 1997-07-03 Visible Genetics Inc. Procede d'evaluation de sequences genetiques polymorphes et leur utilisation pour identifier les types hla

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5629153A (en) * 1990-01-10 1997-05-13 Chiron Corporation Use of DNA-dependent RNA polymerase transcripts as reporter molecules for signal amplification in nucleic acid hybridization assays
ES2267094T3 (es) * 1991-12-23 2007-03-01 Novartis Vaccines And Diagnostics, Inc. Conjunto de sondas de vih para su uso en ensayos de hibridacion en sandwich en fase de disolucion.
AU3094895A (en) * 1994-07-08 1996-02-09 Eleftherios Diamandis Method, reagents and kit for diagnosis and targeted screening for p53 mutations
US6013436A (en) * 1994-07-08 2000-01-11 Visible Genetics, Inc. Compositions and methods for diagnosis of mutation in the von Hippel-Lindau tumor suppressor gene
US5795722A (en) * 1997-03-18 1998-08-18 Visible Genetics Inc. Method and kit for quantitation and nucleic acid sequencing of nucleic acid analytes in a sample

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997023650A2 (fr) * 1995-12-22 1997-07-03 Visible Genetics Inc. Procede d'evaluation de sequences genetiques polymorphes et leur utilisation pour identifier les types hla

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
FRENKEL LM ET AL,JOURNAL OF CLINICAL MICROBIOLOGY,33(2) 342-347 *

Also Published As

Publication number Publication date
EP1017856A1 (fr) 2000-07-12
WO1999016910A1 (fr) 1999-04-08
CA2302201A1 (fr) 1999-04-08
AU9249398A (en) 1999-04-23
JP2001518313A (ja) 2001-10-16

Similar Documents

Publication Publication Date Title
AU718670B2 (en) Method for evaluation of polymorphic genetic sequences, and the use thereof in identification of HLA types
EP0907752B1 (fr) Procede de determination de sequences d'acides nucleiques et leurs applications diagnostiques
Ruano et al. Haplotype of multiple polymorphisms resolved by enzymatic amplification of single DNA molecules.
US5599666A (en) Allelic ladders for short tandem repeat loci
EP0359789B1 (fr) Amplification et detection de sequences d'acides nucleiques
EP0777747B1 (fr) Procede de sequen age de nucleotides
EP0849364B1 (fr) Procédé d'amplification exponentielle et de séquençage directs de molécules d'ADN et son application
JPH05292968A (ja) 核酸増幅のための改善された方法
US5910413A (en) Method and kit for amplification, sequencing and typing of classical HLA class I genes
AU751471B2 (en) Method and kit for evaluation of HIV mutations
US6265152B1 (en) Method and kit for evaluation of HIV mutations
US6007983A (en) Method and kit for evaluation of HIV mutations
AU8846898A (en) Method and kit for hla class i typing dna
WO1998026091A2 (fr) Procede et trousse servant a determiner le type de hla de classe i
JP5530185B2 (ja) 核酸検出方法及び核酸検出用キット
CN109312397A (zh) Penta E基因座多态性人体鉴定
GB2395008A (en) Method and kit for evaluation of HIV mutations
GB2395787A (en) Method and kit for evaluation of HIV mutations
Andersson et al. PCR and DNA sequencing
JP3030038B2 (ja) 液体ハイブリダイゼーションによる遺伝子の分析方法
JPH11299499A (ja) オリゴヌクレオチド

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
PC Assignment registered

Owner name: BAYER HEALTHCARE LLC

Free format text: FORMER OWNER WAS: VISIBLE GENETICS INC.